Smart Implant for Magnetic Anastomotic Healing and Leakage Evaluation
The SMARTHEAL project aims to develop a smart magnetic anastomosis implant with integrated micro-sensors for enhanced healing and early detection of leaks, improving surgical outcomes and reducing costs.
Projectdetails
Introduction
Colorectal cancer affects over 1.93 million people worldwide each year. In most cases, surgery to remove the tumour is necessary, and intestinal continuity is restored through an anastomosis. However, a serious complication, known as an anastomotic leak, occurs in up to 20% of procedures. This complication is associated with high mortality rates, frequent re-interventions, prolonged hospital stays, increased healthcare costs, and a reduced quality of life. Despite decades of research, the incidence of anastomotic leaks remains high, largely due to poor healing and delayed recognition.
Project Overview
Leveraging outcomes from the FET Open project '5D NanoPrinting' and EIC Project 'IV-Lab', Trinity College Dublin and the Istituto Italiano di Tecnologia, in collaboration with Plio Surgical and Amsterdam UMC, aim to integrate the results of micro-sensor and nano-printing technologies into a disruptive smart magnetic anastomosis implant.
Innovative Features
This innovative implant will offer both healing and sensing capabilities, monitoring physical and chemical parameters that signal inflammation and edema at the anastomosis site.
Technology Advancement
The SMARTHEAL project will advance this technology from TRL 3 to TRL 6 by embedding micro-sensors within the implant to detect key markers of anastomotic leaks. These sensors will be integrated with wireless electronics to transmit real-time data on healing biomarkers, with the implant's accuracy demonstrated in pre-clinical models.
Impact and Opportunities
SMARTHEAL represents a groundbreaking advancement, being the first implant to simultaneously enhance healing and enable early leak detection. This innovation has the potential to significantly improve surgical outcomes and reduce healthcare costs globally.
Commercial Potential
It offers a substantial commercial opportunity for Plio Surgical, which aims to undertake the clinical and regulatory activities to bring this technology to market.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.499.815 |
Totale projectbegroting | € 2.499.815 |
Tijdlijn
Startdatum | 1-5-2025 |
Einddatum | 31-10-2027 |
Subsidiejaar | 2025 |
Partners & Locaties
Projectpartners
- THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLINpenvoerder
- FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA
- PLIO SURGICAL LIMITED
- STICHTING AMSTERDAM UMC
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic careMIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally. | EIC Transition | € 2.495.127 | 2022 | Details |
DRUG-ELUTING ELECTRICAL IMPLANT TO REPAIR THE SPINAL CORDDREIMS aims to advance a novel drug-eluting electrical implant for spinal cord repair by refining its design and meeting regulatory standards for human therapeutic use. | EIC Transition | € 2.494.542 | 2023 | Details |
MIRACLE the platform for virtual biopsies; introducing Metabolic MRI-as-a-Service for oncologic care
MIRACLE aims to develop a non-invasive MRI add-on for virtual biopsies, enabling personalized cancer treatment decisions by providing structural and metabolic tumor information globally.
DRUG-ELUTING ELECTRICAL IMPLANT TO REPAIR THE SPINAL CORD
DREIMS aims to advance a novel drug-eluting electrical implant for spinal cord repair by refining its design and meeting regulatory standards for human therapeutic use.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restorationBIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness. | EIC Pathfinder | € 4.039.541 | 2022 | Details |
Mediclose: Towards improved abdominal surgeryHet MIT R&D project ontwikkelt Mediclose, een automatisch chirurgisch instrument voor veilige sluiting van laparoscopische incisies, met als doel post-chirurgische complicaties te verminderen en kosten te verlagen. | Mkb-innovati... | € 315.490 | 2018 | Details |
Implican StaplerImplican BV ontwikkelt een innovatief apparaat om naadlekkage na darmchirurgie te voorkomen door primaire wondgenezing te bevorderen, met als doel sneller herstel en lagere zorgkosten. | Mkb-innovati... | € 20.000 | 2020 | Details |
Smart manufacturing for autologous cell therapies enabled by innovative biomonitoring technologies and advanced process controlThe SMARTER project aims to develop a smart bioprocessing platform for personalized autologous cell therapies, enhancing manufacturing efficiency and enabling clinical use for solid tumors. | EIC Pathfinder | € 1.364.281 | 2022 | Details |
LAPRIXA: the smallest organ blood pressure measurement device in the worldCorporis Medical ontwikkelt een innovatieve bloeddrukmeter om anastomotische lekkage bij slokdarm- en maagresecties te voorspellen. | Mkb-innovati... | € 20.000 | 2020 | Details |
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration
BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.
Mediclose: Towards improved abdominal surgery
Het MIT R&D project ontwikkelt Mediclose, een automatisch chirurgisch instrument voor veilige sluiting van laparoscopische incisies, met als doel post-chirurgische complicaties te verminderen en kosten te verlagen.
Implican Stapler
Implican BV ontwikkelt een innovatief apparaat om naadlekkage na darmchirurgie te voorkomen door primaire wondgenezing te bevorderen, met als doel sneller herstel en lagere zorgkosten.
Smart manufacturing for autologous cell therapies enabled by innovative biomonitoring technologies and advanced process control
The SMARTER project aims to develop a smart bioprocessing platform for personalized autologous cell therapies, enhancing manufacturing efficiency and enabling clinical use for solid tumors.
LAPRIXA: the smallest organ blood pressure measurement device in the world
Corporis Medical ontwikkelt een innovatieve bloeddrukmeter om anastomotische lekkage bij slokdarm- en maagresecties te voorspellen.